Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.

Two key events, namely adhesion and invasion, are pivotal to the occurrence of metastasis. Importantly, the 37 kDa/67 kDa laminin receptor (LRP/LR) has been implicated in enhancing these two events thus facilitating cancer progression. In the current study, the role of LRP/LR in the adhesion and inv...

Full description

Saved in:
Bibliographic Details
Main Authors: Carryn Chetty, Thandokuhle Khumalo, Bianca Da Costa Dias, Uwe Reusch, Stefan Knackmuss, Melvyn Little, Stefan F T Weiss
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096268&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850192014144962560
author Carryn Chetty
Thandokuhle Khumalo
Bianca Da Costa Dias
Uwe Reusch
Stefan Knackmuss
Melvyn Little
Stefan F T Weiss
author_facet Carryn Chetty
Thandokuhle Khumalo
Bianca Da Costa Dias
Uwe Reusch
Stefan Knackmuss
Melvyn Little
Stefan F T Weiss
author_sort Carryn Chetty
collection DOAJ
description Two key events, namely adhesion and invasion, are pivotal to the occurrence of metastasis. Importantly, the 37 kDa/67 kDa laminin receptor (LRP/LR) has been implicated in enhancing these two events thus facilitating cancer progression. In the current study, the role of LRP/LR in the adhesion and invasion of liver cancer (HUH-7) and leukaemia (K562) cells was investigated. Flow cytometry revealed that the HUH-7 cells displayed significantly higher cell surface LRP/LR levels compared to the poorly-invasive breast cancer (MCF-7) control cells, whilst the K562 cells displayed significantly lower cell surface LRP/LR levels in comparison to the MCF-7 control cells. However, Western blotting and densitometric analysis revealed that all three tumorigenic cell lines did not differ significantly with regards to total LRP/LR levels. Furthermore, treatment of liver cancer cells with anti-LRP/LR specific antibody IgG1-iS18 (0.2 mg/ml) significantly reduced the adhesive potential of cells to laminin-1 and the invasive potential of cells through the ECM-like Matrigel, whilst leukaemia cells showed no significant differences in both instances. Additionally, Pearson's correlation coefficients suggested direct proportionality between cell surface LRP/LR levels and the adhesive and invasive potential of liver cancer and leukaemia cells. These findings suggest the potential use of anti-LRP/LR specific antibody IgG1-iS18 as an alternative therapeutic tool for metastatic liver cancer through impediment of the LRP/LR- laminin-1 interaction.
format Article
id doaj-art-bdbf3ea3158c47489cd2da5a661970a7
institution OA Journals
issn 1932-6203
language English
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-bdbf3ea3158c47489cd2da5a661970a72025-08-20T02:14:42ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0195e9626810.1371/journal.pone.0096268Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.Carryn ChettyThandokuhle KhumaloBianca Da Costa DiasUwe ReuschStefan KnackmussMelvyn LittleStefan F T WeissTwo key events, namely adhesion and invasion, are pivotal to the occurrence of metastasis. Importantly, the 37 kDa/67 kDa laminin receptor (LRP/LR) has been implicated in enhancing these two events thus facilitating cancer progression. In the current study, the role of LRP/LR in the adhesion and invasion of liver cancer (HUH-7) and leukaemia (K562) cells was investigated. Flow cytometry revealed that the HUH-7 cells displayed significantly higher cell surface LRP/LR levels compared to the poorly-invasive breast cancer (MCF-7) control cells, whilst the K562 cells displayed significantly lower cell surface LRP/LR levels in comparison to the MCF-7 control cells. However, Western blotting and densitometric analysis revealed that all three tumorigenic cell lines did not differ significantly with regards to total LRP/LR levels. Furthermore, treatment of liver cancer cells with anti-LRP/LR specific antibody IgG1-iS18 (0.2 mg/ml) significantly reduced the adhesive potential of cells to laminin-1 and the invasive potential of cells through the ECM-like Matrigel, whilst leukaemia cells showed no significant differences in both instances. Additionally, Pearson's correlation coefficients suggested direct proportionality between cell surface LRP/LR levels and the adhesive and invasive potential of liver cancer and leukaemia cells. These findings suggest the potential use of anti-LRP/LR specific antibody IgG1-iS18 as an alternative therapeutic tool for metastatic liver cancer through impediment of the LRP/LR- laminin-1 interaction.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096268&type=printable
spellingShingle Carryn Chetty
Thandokuhle Khumalo
Bianca Da Costa Dias
Uwe Reusch
Stefan Knackmuss
Melvyn Little
Stefan F T Weiss
Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
PLoS ONE
title Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
title_full Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
title_fullStr Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
title_full_unstemmed Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
title_short Anti-LRP/LR specific antibody IgG1-iS18 impedes adhesion and invasion of liver cancer cells.
title_sort anti lrp lr specific antibody igg1 is18 impedes adhesion and invasion of liver cancer cells
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0096268&type=printable
work_keys_str_mv AT carrynchetty antilrplrspecificantibodyigg1is18impedesadhesionandinvasionoflivercancercells
AT thandokuhlekhumalo antilrplrspecificantibodyigg1is18impedesadhesionandinvasionoflivercancercells
AT biancadacostadias antilrplrspecificantibodyigg1is18impedesadhesionandinvasionoflivercancercells
AT uwereusch antilrplrspecificantibodyigg1is18impedesadhesionandinvasionoflivercancercells
AT stefanknackmuss antilrplrspecificantibodyigg1is18impedesadhesionandinvasionoflivercancercells
AT melvynlittle antilrplrspecificantibodyigg1is18impedesadhesionandinvasionoflivercancercells
AT stefanftweiss antilrplrspecificantibodyigg1is18impedesadhesionandinvasionoflivercancercells